mhurhangee/patent-ind-claim-en huggingface dataset:
A security service cloud system monitoring a plurality of devices, comprising: one or more processors; a graph model which represents system components and events of the plurality of monitored devices as data objects , wherein each data object has a scope, wherein the scope is one of a device-specific scope , a group-specific scope , or a global scope , wherein the group-specific scope means that the data object with that scope is associated with a collection of monitored devices belonging to a single group of devices and the global scope means that the data object with that scope is associated with all monitored devices represented in the graph model; and one or more modules configured to be operated by the one or more processors to perform one of a plurality of different actions, wherein the one of the plurality of different actions is selected based on the scope of one of the data objects . one or more processors; a graph model which represents system components and events of the plurality of monitored devices as data objects , wherein each data object has a scope, wherein the scope is one of a device-specific scope , a group-specific scope , or a global scope , wherein the group-specific scope means that the data object with that scope is associated with a collection of monitored devices belonging to a single group of devices and the global scope means that the data object with that scope is associated with all monitored devices represented in the graph model; and one or more modules configured to be operated by the one or more processors to perform one of a plurality of different actions, wherein the one of the plurality of different actions is selected based on the scope of one of the data objects .
A method for preparing a magnesium adamantane carboxylate salt, the method comprising: mixing a magnesium salt and a diamondoid compound having at least one carboxylic acid moiety to form a reactant mixture, where the magnesium salt has the formula Mg(OH) 2 ; and hydrothermally treating the reactant mixture at a reaction temperature of from 100 °C to 200 °C for a reaction time of at least 12 hours to form the magnesium adamantane carboxylate salt. mixing a magnesium salt and a diamondoid compound having at least one carboxylic acid moiety to form a reactant mixture, where the magnesium salt has the formula Mg(OH) 2 ; and hydrothermally treating the reactant mixture at a reaction temperature of from 100 °C to 200 °C for a reaction time of at least 12 hours to form the magnesium adamantane carboxylate salt.
An inhibitor of calcineurin of the setron family for use in the treatment of sensorineural hearing loss in a subject in need thereof, wherein sensorineural hearing loss is idiopathic sensorineural hearing loss, noise-induced sensorineural hearing loss, age-related sensorineural hearing loss or ototoxic drug-induced sensorineural hearing loss, and wherein said inhibitor of calcineurin is azasetron or a pharmaceutically acceptable salt thereof.
A transition construction for bridging a building joint between two component parts of a building with at least one cover element that at least partially covers the building joint and can be attached to a component part of the building via an anchoring structure , wherein the anchoring structure is configured such that the at least one cover element is punctually supported thereon, characterized in that the anchoring structure has a tightening means abutting piece for a tightening means formed as a nut or a bolt head on a side facing away from the cover element and the anchoring structure has a spacer that ensures a defined distance between the cover element and the tightening means abutting piece , wherein the spacer and the tightening means abutting piece as a whole form a retaining anchor and that the anchoring structure has a plurality of retaining anchors arranged spaced apart from each other and the punctual support of the cover element is realized such that the cover element in the region of the upper front faces of the retaining anchors rests on the anchoring structure .
T cells transduced to express a chimeric antigen receptor (CAR T cells) for use in treating a hematological malignancy in a human patient, wherein an IL-6 inhibitor is also administered to the patient in order to manage the toxicity resulting from administration of the CAR T cells, further wherein: (i) the CAR comprises an extracellular domain having an antigen recognition domain that targets a tumor antigen, a transmembrane domain, and a cytoplasmic domain; (ii) the CAR T cells are administered as a first-line therapy by infusion, and the IL-6 inhibitor is administered as a second-line therapy; and (iii) the IL-6 inhibitor is selected following detection of an increased IL-6 level in the patient after administering the CAR T cells. (i) the CAR comprises an extracellular domain having an antigen recognition domain that targets a tumor antigen, a transmembrane domain, and a cytoplasmic domain; (ii) the CAR T cells are administered as a first-line therapy by infusion, and the IL-6 inhibitor is administered as a second-line therapy; and (iii) the IL-6 inhibitor is selected following detection of an increased IL-6 level in the patient after administering the CAR T cells.
A method for tissue classification in a region of interest of a subject in a magnetic resonance (MR) image comprising a first region and a second region, wherein the first region represents an air cavity and the second region represents bone , wherein the method comprises the steps of: - acquiring a first magnetic resonance image comprising a representation of the first and the second region and; - inducing a shape change in said air cavity or waiting for a shape change in said air cavity to happen and; - acquiring a second magnetic resonance image comprising a representation of the first and the second region, wherein the first region has a different shape during the acquisition of the second magnetic resonance image compared to during the acquisition of the first magnetic resonance image as a result of inducing said shape change in said air cavity or waiting for said shape change in said air cavity to happen; - identifying the first region and second region in the first and second images and; - comparing the first image and the second image with respect to the representation of the first region and the second region and; - classifying the first region as a region representing air based on a presence of a shape difference between the first and the second images and classifying the second region as bone based on an absence of the shape difference between the first and second images. - acquiring a first magnetic resonance image comprising a representation of the first and the second region and; - inducing a shape change in said air cavity or waiting for a shape change in said air cavity to happen and; - acquiring a second magnetic resonance image comprising a representation of the first and the second region, wherein the first region has a different shape during the acquisition of the second magnetic resonance image compared to during the acquisition of the first magnetic resonance image as a result of inducing said shape change in said air cavity or waiting for said shape change in said air cavity to happen; - identifying the first region and second region in the first and second images and; - comparing the first image and the second image with respect to the representation of the first region and the second region and; - classifying the first region as a region representing air based on a presence of a shape difference between the first and the second images and classifying the second region as bone based on an absence of the shape difference between the first and second images.
An apparatus comprising: a processor ; and memory comprising instructions, which when executed by the processor cause the processor to: receive, from a current sensor, a plurality of sensed current values; wherein the plurality of sensed current values is received at a sampling rate determined by the processor ; further characterized by causing the processor to: remove at least one outlier from a range of recent current values of the plurality of sensed current values, the range being selected by the processor , and the removal being based on a standard deviation across the range of recent current values; derive a variance between the plurality of sensed current values; determine whether the variance is greater than a threshold value and, if yes, increment a variance interval, or, if no, reset a variance interval; and detect an arc between based on the variance interval. a processor ; and memory comprising instructions, which when executed by the processor cause the processor to: receive, from a current sensor, a plurality of sensed current values; wherein the plurality of sensed current values is received at a sampling rate determined by the processor ; further characterized by causing the processor to: remove at least one outlier from a range of recent current values of the plurality of sensed current values, the range being selected by the processor , and the removal being based on a standard deviation across the range of recent current values; derive a variance between the plurality of sensed current values; determine whether the variance is greater than a threshold value and, if yes, increment a variance interval, or, if no, reset a variance interval; and detect an arc between based on the variance interval. remove at least one outlier from a range of recent current values of the plurality of sensed current values, the range being selected by the processor , and the removal being based on a standard deviation across the range of recent current values; derive a variance between the plurality of sensed current values; determine whether the variance is greater than a threshold value and, if yes, increment a variance interval, or, if no, reset a variance interval; and determine whether the variance is greater than a threshold value and, if yes, increment a variance interval, or, if no, reset a variance interval; detect an arc between based on the variance interval.
A locking assembly comprising a pin , a clevis in which the pin is able to be engaged in a reversible manner, and a safety device comprising a clip (20; 120) which comprises an attachment loop (22; 122) and at least one safety tab (24A, 24B; 124A, 124B), the attachment loop (22; 122) being configured to be disposed around at least part of the clevis to cooperate with the latter so as to retain the clip relative to the clevis, the safety tab (24A, 24B; 124A, 124B) being configured to be deformed between a safety position in which it is able to retain the pin engaged in the clevis , and a retracted position in which it allows the withdrawal of the pin relative to the clevis.
Pre-reacted and formaldehyde-free aqueous binding composition, the composition being suitable to bind mineral fibres and comprising one or more reaction products from at least the following components, in percentages by weight on the dry weight of the composition: - at least one reducing sugar in a total amount comprised between 50% and 80%; - at least one sulphamate and/or sulphamic acid in a total amount comprised between 1% and 20%; - at least one amino acid and/or a salt thereof in an amount comprised between 1% and 30%; - at least 2% of a pH-adjusting agent constituted by ammonium hydroxide, an organic and/or inorganic ammonium salt and/or an organic amine or combinations thereof. - at least one reducing sugar in a total amount comprised between 50% and 80%; - at least one sulphamate and/or sulphamic acid in a total amount comprised between 1% and 20%; - at least one amino acid and/or a salt thereof in an amount comprised between 1% and 30%; - at least 2% of a pH-adjusting agent constituted by ammonium hydroxide, an organic and/or inorganic ammonium salt and/or an organic amine or combinations thereof.
A method of fabricating a conductive metal nanowire network, the method comprising: forming a transparent metal nanowire network comprising a plurality of metal nanowires and a plurality of junctions, wherein at least two of the plurality of metal nanowires meet at each of the junctions; immersing the transparent metal nanowire network in a reaction solution; illuminating the immersed network with light for a duration of time sufficient for selective growth of metal nanoparticles at at least a portion of the junctions; removing the illuminated network from the reaction solution; and drying the removed network. forming a transparent metal nanowire network comprising a plurality of metal nanowires and a plurality of junctions, wherein at least two of the plurality of metal nanowires meet at each of the junctions; immersing the transparent metal nanowire network in a reaction solution; illuminating the immersed network with light for a duration of time sufficient for selective growth of metal nanoparticles at at least a portion of the junctions; removing the illuminated network from the reaction solution; and drying the removed network.
An image processing device, comprising: a first motion compensating unit (411-0) that performs motion compensation in decoding of a current view; a first compressing unit (421-0) that compresses a motion vector of the current view to reduce accuracy to a first reduced accuracy; and a second compressing unit (423-0) that compresses the motion vector of the current view at a compression rate higher than a compression rate of the first compressing unit to reduce accuracy to a second reduced accuracy, wherein the second reduced accuracy is lower than the first reduced accuracy, and wherein the first motion compensating unit performs the motion compensation in the decoding of the current view using the motion vector compressed by the second compressing unit, and a second motion compensating unit (411-1) performs motion compensation in the decoding of another view using the motion vector compressed by the first compressing unit. a first motion compensating unit (411-0) that performs motion compensation in decoding of a current view; a first compressing unit (421-0) that compresses a motion vector of the current view to reduce accuracy to a first reduced accuracy; and a second compressing unit (423-0) that compresses the motion vector of the current view at a compression rate higher than a compression rate of the first compressing unit to reduce accuracy to a second reduced accuracy, wherein the second reduced accuracy is lower than the first reduced accuracy, and wherein the first motion compensating unit performs the motion compensation in the decoding of the current view using the motion vector compressed by the second compressing unit, and a second motion compensating unit (411-1) performs motion compensation in the decoding of another view using the motion vector compressed by the first compressing unit.
A disconnection and switch-over device for overvoltage protection, in particular for DC systems having at least one arresting element, moreover a thermal disconnection point , wherein the thermal disconnection point comprises a movable conductor element which is under mechanical pretension and moves in the event of disconnection from a first position into a second position, wherein, when the second position is reached, an electrical switch-over to a fuse is effected, the thermal disconnection point is formed by the movable conductor element and a fixed contact element, wherein the movable conductor element is fixed to the fixed contact element through a thermally triggerable means, characterized in that a complete electrical disconnection of the arresting element with respect to the connection path is only given when the movable conductor element has moved beyond the second position and reached a third position, wherein the fuse is connected in series to the arresting elements , and the movable conductor element is formed as a wiper or sliding contact with regard to the second position, wherein the second position is realized by a bypass end point .
Driving-assistance method comprising a step of: - determining a proposal to change lane, requiring a first validation, characterised in that it also comprises steps of: - determining a proposal to change speed, requiring a second validation, - determining a validation time corresponding to a maximum time during which the driver can validate the proposal to change speed after validation of the proposal to change lane, - if the validation time is less than or equal to a predetermined threshold (S 1 ), then cancelling the proposal to change lane. - determining a proposal to change lane, requiring a first validation, - determining a proposal to change speed, requiring a second validation, - determining a validation time corresponding to a maximum time during which the driver can validate the proposal to change speed after validation of the proposal to change lane, - if the validation time is less than or equal to a predetermined threshold (S 1 ), then cancelling the proposal to change lane.
A forging apparatus comprising: an upper die ; a lower die facing the upper die ; a heating mechanism configured to be able to heat the upper die and the lower die ; and a housing in which the upper die , the lower die , and the heating mechanism are arranged, the upper die and the lower die being configured to be movable relative to each other in a facing direction of the upper die and the lower die so as to be able to forge a forging material (M) between the upper die and the lower die , wherein the housing is integrally formed so as to surround the upper die , the lower die , and the heating mechanism , and comprises a housing body having a charging port opened so as to allow the forging material (M) to pass therethrough, and a door configured to be able to open and close the charging port of the housing body , wherein the heating mechanism is disposed so as to partially or entirely face outer peripheral side surfaces of the upper die and the lower die , the forging apparatus being characterized in that the housing body has an upper die passage port that is opened to allow the upper die to be inserted therethrough so as to be movable in the facing direction, and a lower die passage port that is opened to allow the lower die to be inserted therethrough so as to be movable in the facing direction, in that the housing is configured to be movable in the die facing direction, and in that the heating mechanism is configured to move in the facing direction relatively with respect to the upper die and the lower die moving relatively. an upper die ; a lower die facing the upper die ; a heating mechanism configured to be able to heat the upper die and the lower die ; and a housing in which the upper die , the lower die , and the heating mechanism are arranged, the upper die and the lower die being configured to be movable relative to each other in a facing direction of the upper die and the lower die so as to be able to forge a forging material (M) between the upper die and the lower die , wherein the housing is integrally formed so as to surround the upper die , the lower die , and the heating mechanism , and comprises a housing body having a charging port opened so as to allow the forging material (M) to pass therethrough, and a door configured to be able to open and close the charging port of the housing body , wherein the heating mechanism is disposed so as to partially or entirely face outer peripheral side surfaces of the upper die and the lower die ,
A pro-drug, encapsulated in an inactive configuration, for use in a method for the treatment of cancer characterized in that the method comprises the steps of: a) administering the encapsulated pro-drug to a patient; b) subjecting a target site of the patient dosed with the encapsulated pro-drug to X-ray radiation with a photon energy of up to 250 keV, providing a converging beam with increased average radiation flux cross section area density along longitudinal axis until reaching a maximum at said target site, said converging X-ray beam being of a controllable waist, substantially uniform at said target site, with a maximal absorbed dose rate at said target site, wherein said subjecting to X-ray radiation is sufficient for de-encapsulation of said encapsulated pro-drug, thereby providing the active drug, whilst said X-ray photon dosage at said target site is higher than the X-ray photon dosage at an adjacent non target site. a) administering the encapsulated pro-drug to a patient; b) subjecting a target site of the patient dosed with the encapsulated pro-drug to X-ray radiation with a photon energy of up to 250 keV, providing a converging beam with increased average radiation flux cross section area density along longitudinal axis until reaching a maximum at said target site, said converging X-ray beam being of a controllable waist, substantially uniform at said target site, with a maximal absorbed dose rate at said target site,
An apparatus for ejecting a fluid, - having a control unit for controlling the apparatus, the control unit being configured to control fluid dose ejection steps, during which a fluid dose is ejected from a fluid reservoir through an ejection channel, - wherein the control unit is further configured to determine a priming time length (T prime ), the priming time length (T prime ) being the length of time since the last ejection of a fluid volume through the ejection channel, - wherein the control unit is further configured to perform a priming test step (612 - 618) comprising the steps of: - determining whether the priming time length (T prime ) is longer than a predefined priming threshold time length (T hreshold ), and - if the priming time length (T prime ) is longer than the priming threshold time length (T threshold ), setting the apparatus into a status in which a further fluid dose ejection step is only allowed after execution of an ejection channel priming step (622 - 628). - having a control unit for controlling the apparatus, the control unit being configured to control fluid dose ejection steps, during which a fluid dose is ejected from a fluid reservoir through an ejection channel, - wherein the control unit is further configured to determine a priming time length (T prime ), the priming time length (T prime ) being the length of time since the last ejection of a fluid volume through the ejection channel, - wherein the control unit is further configured to perform a priming test step (612 - 618) comprising the steps of: - determining whether the priming time length (T prime ) is longer than a predefined priming threshold time length (T hreshold ), and - if the priming time length (T prime ) is longer than the priming threshold time length (T threshold ), setting the apparatus into a status in which a further fluid dose ejection step is only allowed after execution of an ejection channel priming step (622 - 628). - determining whether the priming time length (T prime ) is longer than a predefined priming threshold time length (T hreshold ), and - if the priming time length (T prime ) is longer than the priming threshold time length (T threshold ), setting the apparatus into a status in which a further fluid dose ejection step is only allowed after execution of an ejection channel priming step (622 - 628).
Pharmaceutical formulation comprising a deuterated form of tetrahydrocurcumin and a pharmaceutical vehicle for use in treating, inhibiting, or ameliorating a disorder in a subject having a disorder selected from the group consisting of fatty liver disease, alcoholic liver disease, kidney disease, diabetic kidney disease, polycystic kidney disease, hypertension, hypertension with left ventricular hypertrophy, heart failure, diabetes and diabetes with hyperlipidemia.